Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cannabinoids and pain.

¹Imperial College School of Medicine, Department of Anaesthetics, London, UK. a.rice@ic.ac.uk

Current Opinion in Investigational Drugs (London, England : 2000)

|September 29, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.

Journal of thrombosis and haemostasis : JTH·2016

Same author

Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.

Journal of thrombosis and haemostasis : JTH·2015

Same author

Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.

Journal of thrombosis and haemostasis : JTH·2014

Same author

Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study.

Journal of thrombosis and haemostasis : JTH·2013

Same author

Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance.

Journal of thrombosis and haemostasis : JTH·2012

Same author

Mechanisms of neuropathic pain.

British journal of anaesthesia·2001

Same journal

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Current opinion in investigational drugs (London, England : 2000)·2011

Same journal

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Current opinion in investigational drugs (London, England : 2000)·2010

Same journal

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Current opinion in investigational drugs (London, England : 2000)·2010

Same journal

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Current opinion in investigational drugs (London, England : 2000)·2010

Same journal

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Current opinion in investigational drugs (London, England : 2000)·2010

Same journal

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

Current opinion in investigational drugs (London, England : 2000)·2010

See all related articles

Cannabinoid pharmacology research shows strong evidence for pain relief. Further clinical trials for pain management are needed, focusing on cannabinoids with better bioavailability and therapeutic ratios.

Area of Science:

Pharmacology
Neuroscience
Pain Management

Background:

Recent advances have significantly improved understanding of cannabinoid pharmacology.
The endocannabinoid system, including receptors and ligands, has been identified.
Cannabis sativa constituents and synthetic cannabinoids have been isolated and described.

Purpose of the Study:

To review the current understanding of cannabinoid pharmacology regarding pain relief.
To identify potential therapeutic targets for cannabinoid-based analgesia.
To highlight challenges in clinical translation for cannabinoid therapeutics.

Main Methods:

Literature review of recent advances in cannabinoid pharmacology.
Analysis of laboratory evidence supporting cannabinoid analgesia.

Related Experiment Videos

Identification of potential sites of action for cannabinoid-induced pain relief.

Main Results:

Strong laboratory evidence supports the use of cannabinoids for inflammatory and neuropathic pain.
Analgesic effects of cannabinoids have been observed in the brain, spinal cord, and periphery.
The spinal cord and periphery are attractive targets for separating analgesic and psychotropic effects.

Conclusions:

Cannabinoids show promise for pain management, particularly in inflammatory and neuropathic conditions.
Further clinical trials are necessary to validate cannabinoid analgesia.
Development of cannabinoids with improved bioavailability and therapeutic ratios is crucial for clinical success.